TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA

Condition:   Asthma
Interventions:   Drug: CHF 5993 100/6/12.5 µg;   Drug: CHF 1535 100/6 µg
Sponsor:   Chiesi Farmaceutici S.p.A.
Not yet recruiting – verified February 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days